세계의 항체약물접합체 시장 : 작용기서별, 약제별, 기술별, 용도별, 최종사용자별, 지역별 예측(-2027년) - COVID-19의 누적적 영향
Antibody Drug Conjugate Market Research Report by Mechanism of Action, by Drugs, by Technology, by Application, by End User, by Region - Global Forecast to 2027 - Cumulative Impact of COVID-19
상품코드 : 1045224
리서치사 : 360iResearch LLP
발행일 : 2022년 01월
페이지 정보 : 영문 209 Pages
US $ 3,949 ₩ 4,800,000
Online Access (Single User License - 1 Year)
US $ 4,949 ₩ 6,016,000
PDF (Single User License) + Excel
US $ 5,949 ₩ 7,231,000
PDF (1-5 User License) + Excel
US $ 7,949 ₩ 9,662,000
PDF (Site License) + Excel
US $ 9,949 ₩ 12,094,000
PDF (Enterprise License) + Excel


한글목차

세계의 항체약물접합체 시장 규모는 2020년에 37억 8,523만 달러를 기록하고 2021년에는 43억 7,875만 달러에 달할 전망이며, 이후 16.04%의 CAGR로 추이하고 2027년까지 107억 2,758만 달러에 달할 것으로 예상되고 있습니다.

세계의 항체약물접합체 시장에 대해 조사했으며, 시장의 기회 및 과제, 촉진 및 억제요인, COVID-19의 누적적 영향, 작용기서별·약제별·기술별·용도별·최종사용자별·지역별 시장 분석, 경쟁 구도, 주요 기업의 개요 등의 정보를 정리하여 전해드립니다.

목차

제1장 서문

제2장 조사 방법

제3장 개요

제4장 시장 개요

제5장 시장 인사이트

제6장 항체약물접합체 시장 : 작용기서별

제7장 항체약물접합체 시장 : 약제별

제8장 항체약물접합체 시장 : 기술별

제9장 항체약물접합체 시장 : 용도별

제10장 항체약물접합체 시장 : 최종사용자별

제11장 아메리카의 항체약물접합체 시장

제12장 아시아태평양의 항체약물접합체 시장

제13장 유럽, 중동·아프리카의 항체약물접합체 시장

제14장 경쟁 구도

제15장 기업의 유저빌리티 개요

제16장 부록

KSA 22.01.14
영문 목차

영문목차

The Global Antibody Drug Conjugate Market size was estimated at USD 3,785.23 million in 2020 and expected to reach USD 4,378.75 million in 2021, at a CAGR 16.04% to reach USD 10,727.58 million by 2027.

Market Statistics:

The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2019 are considered historical years, 2020 as the base year, 2021 as the estimated year, and years from 2022 to 2027 are considered the forecast period.

Market Segmentation & Coverage:

This research report categorizes the Antibody Drug Conjugate to forecast the revenues and analyze the trends in each of the following sub-markets:

Cumulative Impact of COVID-19:

COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Competitive Strategic Window:

The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes the vendors in the Antibody Drug Conjugate Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:

The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:

The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor's strength and weakness thereby, providing insights to enhance product and service.

Company Usability Profiles:

The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Antibody Drug Conjugate Market, including Abbvie Inc., ADC Therapeutics, Agensys, Inc., Astellas Pharma, AstraZeneca, Bayer AG, Celldex Therapeutics Inc., Concortis Biotherapeutics, Daiichi Sankyo Company Ltd., F. Hoffmann-La Roche Ltd., Gilead Sciences, Inc., GlaxoSmithKline Plc, Immunomedics Inc., Novartis AG, Oxford BioTherapeutics, Pfizer, Inc., Sanofi S.A., Seagen, Inc., Seattle Genetics Inc., Synthon Holding B.V., and Takeda Pharmaceutical Company Ltd..

The report provides insights on the following pointers:

The report answers questions such as:

Table of Contents

1. Preface

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

6. Antibody Drug Conjugate Market, by Mechanism of Action

7. Antibody Drug Conjugate Market, by Drugs

8. Antibody Drug Conjugate Market, by Technology

9. Antibody Drug Conjugate Market, by Application

10. Antibody Drug Conjugate Market, by End User

11. Americas Antibody Drug Conjugate Market

12. Asia-Pacific Antibody Drug Conjugate Market

13. Europe, Middle East & Africa Antibody Drug Conjugate Market

14. Competitive Landscape

15. Company Usability Profiles

16. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기